Study to assess the prevalence of celiac disease in high risk group in Asia
Not Applicable
- Conditions
- Health Condition 1: K598- Other specified functional intestinal disorders
- Registration Number
- CTRI/2019/07/020404
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age 18-60
2. Both genders
3. Willing to participate
4. Patients with Irritable Bowel Syndrome (IBS) and 5. Functional Dyspepsia (FD) as per Rome IV criteria
Exclusion Criteria
1. Previously diagnosed cases of celiac disease
2. Patients on Gluten free diet
3. Refusal to provide consent
4. Pregnant women
5. HIV positive patients
6. Chronic NSAID intake
7. Active smoking
8. Inflammatory bowel disease
9. Dysmorphic features and disproportionate short stature
10. Comorbid severe conditions - pulmonary, renal, liver, cardiac, chronic illness and medication
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method